Urinary Frequency/Urgency
7
0
0
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
14.3%
1 terminated out of 7 trials
75.0%
-11.5% vs benchmark
29%
2 trials in Phase 3/4
67%
2 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (7)
Development of Novel Cystometrics for Overactive Bladder
MRI Guided Transrectal Prostate Laser Ablation for Benign Prostatic Hypertrophy (BPH)
Enhancing Behavioral Treatment for Women With Pelvic Floor Disorders
Transvaginal Botulinum Toxin A Chemodenervation for Overactive Bladder
OnabotulinumtoxinA Bladder Injection Study
Mirabegron for the Treatment of Pain Motivated Urinary Frequency and Urgency in Women
Innovative Minimally Invasive Options in Treatment of Urinary Problems Related to Prostate Enlargement (BPH) in Men